Zomedica Corp. Files Additional Proxy Materials
Ticker: ZOMDF · Form: DEFA14A · Filed: May 13, 2025 · CIK: 1684144
| Field | Detail |
|---|---|
| Company | Zomedica Corp. (ZOMDF) |
| Form Type | DEFA14A |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, regulatory, company-update
TL;DR
Zomedica filed more proxy docs, no new fee. Standard stuff.
AI Summary
Zomedica Corp. filed a Definitive Additional Materials (DEFA14A) proxy statement on May 13, 2025. This filing is related to the company's proxy materials and does not appear to involve a new fee, as indicated by the 'No fee required' checkbox. The filing is for Zomedica Corp., a pharmaceutical preparations company based in Ann Arbor, MI.
Why It Matters
This filing provides updated or supplementary information to shareholders regarding Zomedica Corp.'s corporate governance and voting matters, which is crucial for shareholder engagement and decision-making.
Risk Assessment
Risk Level: low — This is a routine filing of additional proxy materials, not indicating any immediate financial or operational risks.
Key Numbers
- 0001684144 — Central Index Key (Unique identifier for Zomedica Corp. in SEC filings.)
- 001-38298 — SEC File Number (SEC registration number for Zomedica Corp.)
Key Players & Entities
- Zomedica Corp. (company) — Registrant
- 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108 (company) — Business and Mail Address
- 0001654954-25-005527 (dollar_amount) — Accession Number
- 20250513 (dollar_amount) — Filing Date
FAQ
What is the purpose of this DEFA14A filing?
This filing is for Definitive Additional Materials related to Zomedica Corp.'s proxy statement, as indicated by the 'Definitive Additional Materials' checkbox being selected.
When was this filing submitted to the SEC?
The filing was submitted on May 13, 2025, as indicated by the accession number and date as of change.
Is there a fee associated with this filing?
No fee is required for this filing, as indicated by the 'No fee required' checkbox being selected.
What is Zomedica Corp.'s primary business?
Zomedica Corp. is classified under Pharmaceutical Preparations [2834] according to its SIC code.
Where is Zomedica Corp. located?
Zomedica Corp. is located at 100 Phoenix Drive, Suite 125, Ann Arbor, MI 48108.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 13, 2025 regarding Zomedica Corp. (ZOMDF).